<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Selecting treatment sequences â€¢ iviRA</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/simplex/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="Selecting treatment sequences">
<meta property="og:description" content="iviRA">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body data-spy="scroll" data-target="#toc">
    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">iviRA</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="Released version">2.0.0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Tutorial
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/00-intro.html">0. Introduction</a>
    </li>
    <li>
      <a href="../articles/01-population.html">1. Generate population</a>
    </li>
    <li>
      <a href="../articles/02-tx-seqs.html">2. Select treatment sequences</a>
    </li>
    <li>
      <a href="../articles/03-structures.html">3. Select model structures</a>
    </li>
    <li>
      <a href="../articles/04-input-data.html">4. Generate input data</a>
    </li>
    <li>
      <a href="../articles/05-parameters.html">5. Sample parameters</a>
    </li>
    <li>
      <a href="../articles/06-ips.html">6. Run simulation</a>
    </li>
    <li>
      <a href="../articles/07-analysis.html">7. Value assessment</a>
    </li>
  </ul>
</li>
<li>
  <a href="../reference/index.html">API</a>
</li>
<li>
  <a href="../articles/how-to-contribute.html">Collaborate</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    About
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="http://www.thevalueinitiative.org/open-source-value-project/">OSVP</a>
    </li>
    <li>
      <a href="../model-description/model-description.pdf">Model description</a>
    </li>
    <li>
      <a href="../news/index.html">Release history</a>
    </li>
    <li>
      <a href="../articles/reproducibility.html">Reproducibility</a>
    </li>
    <li>
      <a href="../articles/hesim.html">hesim</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Web apps
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="https://ivi-ra-expert.clarityviz.com/">IVI-RA Model Interface</a>
    </li>
    <li>
      <a href="https://ivi-ra.clarityviz.com/">IVI-RA Value Tool</a>
    </li>
  </ul>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/InnovationValueInitiative/IVI-RA/">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      

      </header><script src="02-tx-seqs_files/accessible-code-block-0.0.1/empty-anchor.js"></script><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip>Selecting treatment sequences</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/InnovationValueInitiative/IVI-RA/blob/master/vignettes/02-tx-seqs.Rmd"><code>vignettes/02-tx-seqs.Rmd</code></a></small>
      <div class="hidden name"><code>02-tx-seqs.Rmd</code></div>

    </div>

    
    
<div id="available-treatments" class="section level2">
<h2 class="hasAnchor">
<a href="#available-treatments" class="anchor"></a>Available treatments</h2>
<p>The primary purpose of the model is to simulate health and cost outcomes for patients with RA treated as a function of the treatments use. Since patients typically use multiple treatments over a lifetime, the model is capable of simulating a treatment sequence of any arbitrary length. Treatments that can be included in a sequence are cDMARDs, bDMARDs, and JAK/STAT inhibitors. We refer to bDMARDs and JAK/STAT inhibitors collectively as targeted DMARDs (tDMARDs).</p>
<p>A dataset of available treatments loads with the <code>iviRA</code> package. The <code>name</code>, <code>mname</code>, and <code>sname</code> columns are long-form, medium-form, and short-form names, respectively. The column <code>route</code> refers to route of administration; if a treatment is a combination therapy, then all routes of administration in the combination are listed. Finally, <code>approval_date</code> is the date that a treatment was approved by the FDA in the US and <code>years_since_approval</code> is the number of years (from the last update of the model) since the treatment was approved.</p>
<div class="sourceCode" id="cb1"><html><body><pre class="r"><span class="kw pkg">iviRA</span><span class="kw ns">::</span><span class="no"><a href="../reference/treatments.html">treatments</a></span></pre></body></html></div>
<pre><code>##                                                            name           mname
##  1:                                                     cDMARDs         cDMARDs
##  2:                                 abatacept IV + methotrexate    ABT IV + MTX
##  3:                                 abatacept SC + methotrexate    ABT SC + MTX
##  4:                                   adalimumab + methotrexate       ADA + MTX
##  5:                                                  adalimumab             ADA
##  6: adalimumab-bwwd (biosimilar Samsung Bioepis) + methotrexate  ADA BWWD + MTX
##  7:                                     anakinra + methotrexate       ANA + MTX
##  8:                                                 baricitinib             BCT
##  9:                                  baricitinib + methotrexate       BCT + MTX
## 10:                                          certolizumab pegol             CZP
## 11:                           certolizumab pegol + methotrexate       CZP + MTX
## 12:                                                  etanercept             ETN
## 13:                                   etanercept + methotrexate       ETN + MTX
## 14:          etanercept-szzs (biosimilar Sandoz) + methotrexate  ETN SZZS + MTX
## 15: etanercept-ykro (biosimilar Samsung Bioepis) + methotrexate  ETN YKRO + MTX
## 16:                                                   golimumab             GOL
## 17:                                    golimumab + methotrexate       GOL + MTX
## 18:                                   infliximab + methotrexate       IFX + MTX
## 19:          infliximab-qbtx (biosimilar Pfizer) + methotrexate  IFX QBTX + MTX
## 20:                                                     placebo         Placebo
## 21:                                                non/biologic             NBT
## 22:                                                   rituximab             RTX
## 23:                                    rituximab + methotrexate       RTX + MTX
## 24:                                                   sarilumab             SAR
## 25:                                    sarilumab + methotrexate       SAR + MTX
## 26:           sulfasalazine + hydroxychloroquine + methotrexate SSZ + HCQ + MTX
## 27:                                                 tocilizumab             TCZ
## 28:                                  tocilizumab + methotrexate       TCZ + MTX
## 29:                                  tofacitinib + methotrexate       TOF + MTX
## 30:                                                 tofacitinib             TOF
## 31:                                 upadacitinib + methotrexate       UPA + MTX
##                                                            name           mname
##              sname              route approval_date years_since_approval
##  1:        cdmards          injection      12/31/88            31.956254
##  2:       abtivmtx infusion/injection      12/23/05            15.002051
##  3:       abtscmtx          injection        8/2/11             9.402597
##  4:         adamtx          injection      12/31/02            17.976760
##  5:            ada          injection      12/31/02            17.976760
##  6: adabiosbwwdmtx          injection       7/23/18             2.438824
##  7:         anamtx          injection      12/31/02            17.976760
##  8:            bct               oral       5/31/18             2.583732
##  9:         bctmtx               oral       5/31/18             2.583732
## 10:            czp          injection       4/22/08            12.675325
## 11:         czpmtx          injection       4/22/08            12.675325
## 12:            etn          injection       11/2/98            22.132604
## 13:         etnmtx          injection       11/2/98            22.132604
## 14: etnbiosszzsmtx          injection       8/30/16             4.330827
## 15: etnbiosykromtx          injection       4/25/19             1.684211
## 16:            gol          injection       4/24/09            11.671907
## 17:         golmtx          injection       4/24/09            11.671907
## 18:         ifxmtx infusion/injection      11/10/99            21.112782
## 19: ifxbiosqbtxmtx infusion/injection      12/13/17             3.045796
## 20:        placebo               none      12/31/88            31.956254
## 21:            nbt          injection      12/31/88            31.956254
## 22:            rtx          injection       2/28/06            14.818865
## 23:         rtxmtx infusion/injection       2/28/06            14.818865
## 24:            sar          injection      22/05/17             0.100000
## 25:         sarmtx          injection      22/05/17             0.100000
## 26:         triple          injection      12/31/02            17.976760
## 27:            tcz          injection      10/21/13             7.185236
## 28:         tczmtx          injection      10/21/13             7.185236
## 29:         tofmtx     oral/injection       11/6/12             8.139440
## 30:            tof               oral       11/6/12             8.139440
## 31:         upamtx               oral       8/16/19             1.375256
##              sname              route approval_date years_since_approval</code></pre>
</div>
<div id="selecting-treatments" class="section level2">
<h2 class="hasAnchor">
<a href="#selecting-treatments" class="anchor"></a>Selecting treatments</h2>
<p>To run the model, we must specify a treatment sequence. The treatment sequence can consist of a single sequence of treatments for all patients in the population or can vary for each patient.</p>
<p>For example, suppose that we want to simulate a treatment sequence of three biologics: adalimumab + methotrexate, etanercept + methotrexate, and infliximab + methotrexate. They should be specified as a vector with elements matching the <code>sname</code> in <code><a href="../reference/treatments.html">iviRA::treatments</a></code>. For comparison purposes, we might want to also simulate outcomes for a non-biologic treatment sequence of only cDMARDs.</p>
<div class="sourceCode" id="cb3"><html><body><pre class="r"><span class="no">txseq1</span> <span class="kw">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html">c</a></span>(<span class="st">"adamtx"</span>, <span class="st">"etnmtx"</span>, <span class="st">"ifxmtx"</span>)
<span class="no">txseq2</span> <span class="kw">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html">c</a></span>(<span class="st">"cdmards"</span>)</pre></body></html></div>
<p>In some cases, it might also be useful to allow treatments to differ across patients. This could be useful when, for example, comparing treatment strategies that tailor treatment to individuals against one size fits all strategies. This can be done by creating a matrix of treatment sequences where the number of rows is equal to the number of patients in the cohort. Below we consider a scenario where some patients receive one of two sequences:</p>
<ol style="list-style-type: decimal">
<li>adalimumab + methotrexate -&gt; etanercept + methotrexate -&gt; infliximab + methotrexate</li>
<li>etanercept + methotrexate -&gt; adalimumab + methotrexate -&gt; infliximab + methotrexate</li>
</ol>
<div class="sourceCode" id="cb4"><html><body><pre class="r"><span class="no">txseq.mat</span> <span class="kw">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/matrix.html">matrix</a></span>(<span class="fu"><a href="https://rdrr.io/r/base/c.html">c</a></span>(<span class="st">"adamtx"</span>, <span class="st">"etnmtx"</span>, <span class="st">"ifxmtx"</span>, <span class="st">"etnmtx"</span>, <span class="st">"adamtx"</span>, <span class="st">"ifxmtx"</span>),
                     <span class="kw">nrow</span> <span class="kw">=</span> <span class="fu"><a href="https://rdrr.io/r/base/nrow.html">nrow</a></span>(<span class="no">pop</span>), <span class="kw">ncol</span> <span class="kw">=</span> <span class="fl">3</span>, <span class="kw">byrow</span> <span class="kw">=</span> <span class="fl">TRUE</span>)
<span class="fu"><a href="https://rdrr.io/r/utils/head.html">head</a></span>(<span class="no">txseq.mat</span>)</pre></body></html></div>
<pre><code>##      [,1]     [,2]     [,3]    
## [1,] "adamtx" "etnmtx" "ifxmtx"
## [2,] "etnmtx" "adamtx" "ifxmtx"
## [3,] "adamtx" "etnmtx" "ifxmtx"
## [4,] "etnmtx" "adamtx" "ifxmtx"
## [5,] "adamtx" "etnmtx" "ifxmtx"
## [6,] "etnmtx" "adamtx" "ifxmtx"</code></pre>
<div class="sourceCode" id="cb6"><html><body><pre class="r"><span class="fu"><a href="https://rdrr.io/r/base/nrow.html">nrow</a></span>(<span class="no">txseq.mat</span>)</pre></body></html></div>
<pre><code>## [1] 100</code></pre>
<div class="sourceCode" id="cb8"><html><body><pre class="r"><span class="fu"><a href="https://rdrr.io/r/base/nrow.html">nrow</a></span>(<span class="no">pop</span>)</pre></body></html></div>
<pre><code>## [1] 100</code></pre>
<div>
<ul class="pager">
<li class="previous">
<a href="01-population.html">Previous</a>
</li>
<li class="next">
<a href="03-structures.html">Next</a>
</li>
</ul>
</div>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

        <nav id="toc" data-toggle="toc"><h2 data-toc-skip>Contents</h2>
    </nav>
</div>

</div>



      <footer><div class="copyright">
  <p>Developed by Jeroen P. Jansen, Devin Incerti.</p>
</div>

<div class="pkgdown">
  <p>Site built with <a href="https://pkgdown.r-lib.org/">pkgdown</a> 1.5.1.</p>
</div>

      </footer>
</div>

  


  </body>
</html>
